About Us
Since its foundation in 1964, Hänseler AG has been an innovative Swiss manufacturing and trading company in the pharmaceutical and healthcare industry, based in Herisau.
Hänseler AG is successful on three levels. The company's three mainstays are trading and processing of raw materials, manufacturing and distribution of OTC products, and production and packaging on behalf of partner companies.
As the Swiss market leader for pharmaceutical raw materials, we carry over 3‘000 raw materials and renowned brands such as Gly-Coramine®, Original Bach®-Blüten/RESCUE®, OLBAS® and the Kidney and Bladder Dragées S in the range. Most of the 1’800 Swiss pharmacies and 400 drugstores as well as numerous industrial/export customers use the competence and quality made in Herisau.
Most of the 1‘800 pharmacies and 400 drugstores in Switzerland are Hänseler customers and, like industrial and export customers, are served competently and with commitment by our total of 135 employees.
Our core competencies
Pharmaceutics
We supply almost the entire Swiss specialist trade with a broad range of OTC preparations for a wide variety of applications.Discover our product world
Industry
We support you in all aspects of pharmaceutical-industrial manufacturing - from procurement, production and packaging to successful market development. How we can support you
Raw materials
We offer a wide range of raw materials in various containers and sizes, either as commercial products or from our own production, comprising more than 3'000 different products. Discover our range of raw materials
Growth over decades
The history of Hänseler AG begins in 1964 with Edwin Hänseler, who built up a flourishing trade by manufacturing pharmaceutical preparations. At the turn of the millennium, the company was expanded with a large-scale new building and extension. Today, Hänseler AG employs 135 people, who personally handle around 4,200 customer contacts per year and around 600 deliveries per day. Further expansion projects at the Herisau site are being planned.
1964
Edwin Hänseler starts manufacturing and trading pharmaceutical products
1975
Entry in the commercial register as Hänseler AG in Herisau
2004
Acquisition of the majority of shares by Steinegg Foundation, Herisau
2006
Extensive new construction and conversion work
2009
Pioneer in the development of GID intermediates (raw materials)
2010
Acquisition of the Alcacyl® and Gly-Coramin® brands
2013
New corporate design
2015
Entry into the Asian market with Planox®
2015
Building business model with medical cannabis (THC)
2016
Entry into the retail market in Switzerland
2018
National THMP approvals in Spain, Norway and Sweden
2020
Brand takeover of Kelosoft®, launch of Hänseler Forte and Hänseler Achillea. Biocide approval and launch of Hänseler Desinfect range.
2021
Introduction kidney and bladder dragéess in Norway
2022
FDA audit successfully passed
2023
Groundbreaking ceremony for the new building M
Worth knowing at a glance
Hänseler AG is an independent, financially autonomous pharmaceutical company. The main shareholder is the Steinegg Foundation, which is domiciled in Herisau. This foundation is committed to maintaining a healthy economic structure in the region.The investments made in personnel and infrastructure in recent years and the expansion of our market position have created key conditions for the healthy and sustainable development of our company.